Mar 25, 2008
NASHVILLE, March 25, 2008 – Veran Medical Technologies will be exhibiting navigated PET-CT data at WCIO 2008 (World Conference of Interventional Oncology). The WCIO Annual Scientific Meeting partnered with the Best of ASCO (American Society of Clinical Oncology) will be held June 22-25 in Los Angeles, CA. Veran will be in Booth #140. “Continuing to integrate feature rich PET-CT data into our 4D navigation system is a natural progression,” said Jerome R. Edwards, President and CEO of Veran Medical Technologies. “Linked with our Plug-n-Play delivery this capability really separates us from our competition. WCIO 2008’s focus on Synergies of the Future highlighting tracks in Clinical Oncology, Image guided Intervention, and Multimodality Therapy really represents our sweet spot.”
Veran is a privately held medical device company headquartered in St. Louis, MO. The company’s mission is to empower physicians to diagnose cancer earlier and to enable precision therapy to save lives. In the United States, lung cancer kills more people each year than breast, prostate, pancreatic and colon cancers combined.
Veran has developed and commercialized an FDA cleared, next generation electromagnetic thoracic navigation platform called the SPiN Thoracic Navigation System™. Veran’s breakthrough technology has been adopted by leading cancer centers throughout the United States. Veran provides physicians with a full line of bronchoscopic brushes, needles, forceps and steerable catheters with tiny electromagnetic sensors embedded in the tips for precise navigation. The combination of these proprietary Always-On Tip Tracked® instruments and Veran’s exclusive patient respiratory gating technology enables physicians to accurately access lung nodules by accounting for nodule movement during patient breathing, a common challenge for lung specialists.
Another challenge lung specialists face is that approximately 40% of lung nodules lie outside of an airway, making them very difficult to reach endobronchially, and traditionally requiring an additional procedure. Veran’s SPiN Thoracic Navigation System™ is the first and only FDA cleared technology that enables Pulmonologists or Thoracic Surgeons to safely and accurately access lung nodules outside of an airway using SPiN Perc™, a navigated transthoracic needle. With SPiN Perc™, Veran combines endobronchial navigation with percutaneous navigation, allowing physicians to access all lung nodules in a single procedure, regardless of nodule size or location. This eliminates the cost and risk of unnecessary procedures and empowers physicians to provide a same day diagnosis for their patients. The early diagnosis and treatment of lung cancer has been proven to save lives.